Benzamide inhibitors of the P2X 7 receptor

Details Benzamide inhibitors of the P2X 7 receptor Benzamide inhibitors of the P2X 7 receptor

2007-01-08

2008-08-05

Balasubram, Venkataraman (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S182000

Reexamination Certificate

active

07407956

ABSTRACT:
The present invention provides benzamide inhibitors of the P2X7receptor of the formula:wherein R1-R3are as defined herein. The compounds of the invention are useful in the treatment of IL-1 mediated disorders, including, without limitation, inflammatory diseases such as osteoarthritis and rheumatoid arthritis; allergies, asthma, COPD, cancer, reperfusion or ischemia in stroke or heart attack, autoimmune diseases and other disorders.

REFERENCES:
patent: 4594099 (1986-06-01), Yamada et al.
patent: 4766233 (1988-08-01), Lyga
patent: 4906286 (1990-03-01), Lyga
patent: 4906287 (1990-03-01), Lyga et al.
patent: 5077409 (1991-12-01), Wissner
patent: 5128351 (1992-07-01), Wissner
patent: 5691376 (1997-11-01), Caggiano et al.
patent: 5773646 (1998-06-01), Chandrakumar et al.
patent: 5948803 (1999-09-01), Maeda et al.
patent: 5961376 (1999-10-01), Gottschald
patent: 6020357 (2000-02-01), Pinto et al.
patent: 6180844 (2001-01-01), Fujita et al.
patent: 6187797 (2001-02-01), Pruitt et al.
patent: 6201024 (2001-03-01), Baxter et al.
patent: 6218376 (2001-04-01), Kindom et al.
patent: 6258838 (2001-07-01), Baxter et al.
patent: 6492355 (2002-12-01), Alcaraz et al.
patent: 6927219 (2005-08-01), Duplantier
patent: 6974812 (2005-12-01), Dombroski et al.
patent: 7176202 (2007-02-01), Dombroski et al.
patent: 2003/0186981 (2003-10-01), Duplantier et al.
patent: 2005/0009900 (2005-01-01), Dombroski et al.
patent: 2005/0288256 (2005-12-01), Li
patent: 2005/0288288 (2005-12-01), Leonard et al.
patent: 2006/0058302 (2006-03-01), Duplantier et al.
patent: 0 077 938 (1983-05-01), None
patent: 0 138 527 (1985-04-01), None
patent: 138 527 (1985-04-01), None
patent: 0 514 339 (1992-11-01), None
patent: 0 563 384 (1993-10-01), None
patent: 0 688 773 (1995-12-01), None
patent: 0 877 018 (1998-11-01), None
patent: 0 974 576 (2000-01-01), None
patent: WO 86/00072 (1986-01-01), None
patent: WO 89/02891 (1989-04-01), None
patent: WO 92/11242 (1992-07-01), None
patent: WO 93/04686 (1993-03-01), None
patent: WO 95/22532 (1995-08-01), None
patent: WO 95/27513 (1995-10-01), None
patent: WO 96/38428 (1996-12-01), None
patent: WO 97/22600 (1997-06-01), None
patent: WO 97/23212 (1997-07-01), None
patent: WO 98/28269 (1998-07-01), None
patent: WO 98/42669 (1998-10-01), None
patent: WO 98/43973 (1998-10-01), None
patent: WO 99/17777 (1999-04-01), None
patent: WO 99/29660 (1999-06-01), None
patent: WO 99/29661 (1999-06-01), None
patent: WO 99/29686 (1999-06-01), None
patent: WO 00/17190 (2000-03-01), None
patent: WO 00/27808 (2000-05-01), None
patent: WO 00/35864 (2000-06-01), None
patent: WO 00/71529 (2000-11-01), None
patent: WO 01/23378 (2001-04-01), None
patent: WO 01/28498 (2001-04-01), None
patent: WO 01/42194 (2001-06-01), None
patent: WO 01/44170 (2001-06-01), None
patent: WO 01/44213 (2001-06-01), None
patent: WO 03/042190 (2003-05-01), None
patent: WO 03/042191 (2003-05-01), None
Dowd et al., “P2X Receptor-Mediated Excitation of Nociceptive Afferents in the Normal and Arthritic Rat Knee Joint”, British Journal of Pharmacology, 1998, pp. 341-346, vol. 125 No. 2.
Goldbalt, et al., “New Therapies for Rheumatoid Arthritis”, Clin Exp Immunol, 2005, vol. 140 No. 2, pp. 195-204.
West, Anthony R, et al., “Solid State Chemistry and its Applications”, Wiley, New York, 1988, pp. 358 & 365.
Vippagunta, et al., “Crystalline Solids”, Advanced Drug Delivery Reviews, 2001, vol. 48, pp. 3-26.
U.S. Appl. No. 10/748,342, filed Dec. 30, 2003, Dombroski et al.
U.S. Appl. No. 11/168,602, filed Jun. 28, 2005, Chung et al.
U.S. Appl. No. 11/260,075, filed Oct. 27, 2005, Dombroski et al.
Bowers et al., “Pharmacological Analysis of the P2Z-Purinoceptor Present on THP-1 Cells”, Drug Development Research, vol. 37, No. 3, 1996, p. 126.
International Search Report, PCT/IB03/06254, mailed Apr. 5, 2004.
International Search Report, PCT/IB02/04613, mailed Dec. 30, 2002.
Theodoridis et al., “Synthesis and Structure-Activity Relationships of 1-Aryl-4-substituted-1,4-dihydro-5H-tetrazol-5-ones, a Novel Class of Pre- and Post-emergence Herbicides”, Pestic. Sci., vol. 30, 1990, pp. 259-274.
Theodoridis et al., “Synthesis and Herbicidal Properties of Aryltriazolinones”, American Chemical Society, Synthesis and Chemistry of Agrochemicals III, Chapter 14, 1992, pp. 134-146.
Lyga et al., “Synthesis, Herbicidal Activity, and Action Mechanism of 2-Aryl-1,2,4-triazine-3,5-diones”, American Chemical Society, Synthesis and Chemistry of Agrochemicals II, Chapter 14, 1991, pp. 170-181.

Affiliated with

Also associated with

Rating

Benzamide inhibitors of the P2X 7 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzamide inhibitors of the P2X 7 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzamide inhibitors of the P2X 7 receptor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4007863